Shuang Li

Title: Shuang Li: Innovator in Lipid Nanoparticle Technology

Introduction

Shuang Li is a notable inventor based in Belmont, CA, who has made significant contributions to the field of lipid nanoparticle technology. With a focus on innovative methods for delivering therapeutic agents, he has been instrumental in advancing treatments for respiratory conditions.

Latest Patents

Shuang Li holds 2 patents related to lipid nanoparticle compositions. His latest patents include methods for delivering lipid nanoparticles (LNPs) to lung cells of subjects suffering from or at risk for primary ciliary dyskinesia (PCD). The methods involve nebulizing a liquid pharmaceutical composition to generate an aerosolized pharmaceutical composition, which is then administered to the subject. This innovative approach aims to improve the delivery and efficacy of treatments for individuals with PCD.

Career Highlights

Shuang Li is currently associated with Recode Therapeutics, Inc., where he continues to develop cutting-edge solutions in the field of biotechnology. His work focuses on enhancing the delivery mechanisms of lipid nanoparticles, which are crucial for effective therapeutic interventions.

Collaborations

Shuang Li collaborates with esteemed colleagues, including Vladimir Grigor'evich Kharitonov and Sakya Sing Mohapatra. These partnerships foster a collaborative environment that enhances research and development efforts in lipid nanoparticle technology.

Conclusion

Shuang Li's contributions to lipid nanoparticle technology represent a significant advancement in the treatment of respiratory diseases. His innovative methods and collaborative efforts continue to pave the way for future breakthroughs in biotechnology.